Exosome Therapeutics Market Size to Hit USD 4,020.75 Thousand by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Exosome Therapeutics Market

5.1. COVID-19 Landscape: Exosome Therapeutics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Exosome Therapeutics Market, By Source

8.1. Exosome Therapeutics Market, by Source

8.1.1. Mesenchymal Stem Cells (MSCs)

8.1.1.1. Market Revenue and Forecast

8.1.2. Immune Cells

8.1.2.1. Market Revenue and Forecast

8.1.3. Dendritic Cells

8.1.3.1. Market Revenue and Forecast

8.1.4. Platelets

8.1.4.1. Market Revenue and Forecast

8.1.5. Tumor Cells

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Exosome Therapeutics Market, By Therapeutic Application

9.1. Exosome Therapeutics Market, by Therapeutic Application

9.1.1. Oncology

9.1.1.1. Market Revenue and Forecast

9.1.2. Neurology

9.1.2.1. Market Revenue and Forecast

9.1.3. Cardiovascular Diseases

9.1.3.1. Market Revenue and Forecast

9.1.4. Infectious Diseases

9.1.4.1. Market Revenue and Forecast

9.1.5. Regenerative Medicine

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Exosome Therapeutics Market, By Delivery Mechanism

10.1. Exosome Therapeutics Market, by Delivery Mechanism

10.1.1. Intravenous (IV)

10.1.1.1. Market Revenue and Forecast

10.1.2. Intratumoral

10.1.2.1. Market Revenue and Forecast

10.1.3. Local/Topical Administration

10.1.3.1. Market Revenue and Forecast

10.1.4. Intranasal

10.1.4.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Exosome Therapeutics Market, By Technology

11.1. Exosome Therapeutics Market, by Technology

11.1.1. Isolation & Purification Technologies

11.1.1.1. Market Revenue and Forecast

11.1.2. Engineering Technologies

11.1.2.1. Market Revenue and Forecast

Chapter 12. Global Exosome Therapeutics Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Source

12.1.2. Market Revenue and Forecast, by Therapeutic Application

12.1.3. Market Revenue and Forecast, by Delivery Mechanism

12.1.4. Market Revenue and Forecast, by Technology

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Source

12.1.5.2. Market Revenue and Forecast, by Therapeutic Application

12.1.5.3. Market Revenue and Forecast, by Delivery Mechanism

12.1.5.4. Market Revenue and Forecast, by Technology

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Source

12.1.6.2. Market Revenue and Forecast, by Therapeutic Application

12.1.6.3. Market Revenue and Forecast, by Delivery Mechanism

12.1.6.4. Market Revenue and Forecast, by Technology

12.2. Europe

12.2.1. Market Revenue and Forecast, by Source

12.2.2. Market Revenue and Forecast, by Therapeutic Application

12.2.3. Market Revenue and Forecast, by Delivery Mechanism

12.2.4. Market Revenue and Forecast, by Technology

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Source

12.2.5.2. Market Revenue and Forecast, by Therapeutic Application

12.2.5.3. Market Revenue and Forecast, by Delivery Mechanism

12.2.5.4. Market Revenue and Forecast, by Technology

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Source

12.2.6.2. Market Revenue and Forecast, by Therapeutic Application

12.2.6.3. Market Revenue and Forecast, by Delivery Mechanism

12.2.6.4. Market Revenue and Forecast, by Technology

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Source

12.2.7.2. Market Revenue and Forecast, by Therapeutic Application

12.2.7.3. Market Revenue and Forecast, by Delivery Mechanism

12.2.7.4. Market Revenue and Forecast, by Technology

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Source

12.2.8.2. Market Revenue and Forecast, by Therapeutic Application

12.2.8.3. Market Revenue and Forecast, by Delivery Mechanism

12.2.8.4. Market Revenue and Forecast, by Technology

12.3. APAC

12.3.1. Market Revenue and Forecast, by Source

12.3.2. Market Revenue and Forecast, by Therapeutic Application

12.3.3. Market Revenue and Forecast, by Delivery Mechanism

12.3.4. Market Revenue and Forecast, by Technology

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Source

12.3.5.2. Market Revenue and Forecast, by Therapeutic Application

12.3.5.3. Market Revenue and Forecast, by Delivery Mechanism

12.3.5.4. Market Revenue and Forecast, by Technology

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Source

12.3.6.2. Market Revenue and Forecast, by Therapeutic Application

12.3.6.3. Market Revenue and Forecast, by Delivery Mechanism

12.3.6.4. Market Revenue and Forecast, by Technology

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Source

12.3.7.2. Market Revenue and Forecast, by Therapeutic Application

12.3.7.3. Market Revenue and Forecast, by Delivery Mechanism

12.3.7.4. Market Revenue and Forecast, by Technology

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Source

12.3.8.2. Market Revenue and Forecast, by Therapeutic Application

12.3.8.3. Market Revenue and Forecast, by Delivery Mechanism

12.3.8.4. Market Revenue and Forecast, by Technology

12.4. MEA

12.4.1. Market Revenue and Forecast, by Source

12.4.2. Market Revenue and Forecast, by Therapeutic Application

12.4.3. Market Revenue and Forecast, by Delivery Mechanism

12.4.4. Market Revenue and Forecast, by Technology

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Source

12.4.5.2. Market Revenue and Forecast, by Therapeutic Application

12.4.5.3. Market Revenue and Forecast, by Delivery Mechanism

12.4.5.4. Market Revenue and Forecast, by Technology

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Source

12.4.6.2. Market Revenue and Forecast, by Therapeutic Application

12.4.6.3. Market Revenue and Forecast, by Delivery Mechanism

12.4.6.4. Market Revenue and Forecast, by Technology

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Source

12.4.7.2. Market Revenue and Forecast, by Therapeutic Application

12.4.7.3. Market Revenue and Forecast, by Delivery Mechanism

12.4.7.4. Market Revenue and Forecast, by Technology

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Source

12.4.8.2. Market Revenue and Forecast, by Therapeutic Application

12.4.8.3. Market Revenue and Forecast, by Delivery Mechanism

12.4.8.4. Market Revenue and Forecast, by Technology

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Source

12.5.2. Market Revenue and Forecast, by Therapeutic Application

12.5.3. Market Revenue and Forecast, by Delivery Mechanism

12.5.4. Market Revenue and Forecast, by Technology

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Source

12.5.5.2. Market Revenue and Forecast, by Therapeutic Application

12.5.5.3. Market Revenue and Forecast, by Delivery Mechanism

12.5.5.4. Market Revenue and Forecast, by Technology

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Source

12.5.6.2. Market Revenue and Forecast, by Therapeutic Application

12.5.6.3. Market Revenue and Forecast, by Delivery Mechanism

12.5.6.4. Market Revenue and Forecast, by Technology

Chapter 13. Company Profiles

13.1. EV Therapeutics

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. StemXO Therapeutics

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Codiak BioSciences

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. ExoCoBio

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. ILIAS Biologics

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Regeneus

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Innovex Therapeutics

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Brexogen

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Organicell Regenerative Medicine

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Direct Biologics

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The exosome therapeutics market size is expected to increase from USD 789.37 thousand in 2024 to USD 4,020.75 thousand by 2034.

The exosome therapeutics market is expected to grow at a compound annual growth rate (CAGR) of around 17.68% from 2025 to 2034.

The major players in the exosome therapeutics market include EV Therapeutics, StemXO Therapeutics, Codiak BioSciences, ExoCoBio, ILIAS Biologics, Regeneus, Innovex Therapeutics, Brexogen, Organicell Regenerative Medicine, Direct Biologics, Exostemtech, OmniSpirant, ShiftBio Inc., Aruna Bio, and Kimera Labs.

The driving factors of the exosome therapeutics market are the increasing prevalence of chronic, infectious, autoimmune, and neurodegenerative diseases, rapid advancements in exosome isolation, and rising investments in healthcare infrastructure.

North America region will lead the global exosome therapeutics market during the forecast period 2025 to 2034.